Eurofins-Cerep SA Net Assets
Eurofins-Cerep SA net assets. Based on the latest financial reports, Eurofins-Cerep SA (ALECR) has net assets worth €76.41 Million EUR (≈ $89.33 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€88.84 Million ≈ $103.86 Million USD) and total liabilities (€12.43 Million ≈ $14.53 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore ALECR year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €76.41 Million |
| % of Total Assets | 86.01% |
| Annual Growth Rate | 7.7% |
| 5-Year Change | 68.39% |
| 10-Year Change | 337.69% |
| Growth Volatility | 30.69 |
Net Assets of Eurofins-Cerep SA (2000–2025)
Net assets of Eurofins-Cerep SA from 2000 to 2025. This chart illustrates how Eurofins-Cerep SA's net assets have evolved over time, based on quarterly financial data. See Eurofins-Cerep SA net asset quality index to measure how much of total assets are equity-financed.
Annual Net Assets for Eurofins-Cerep SA (2000–2025)
The table below shows the annual net assets of Eurofins-Cerep SA from 2000 to 2025. For live market cap and overall valuation, see Eurofins-Cerep SA market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €76.41 Million ≈ $89.33 Million |
+6.51% |
| 2024-12-31 | €71.74 Million ≈ $83.87 Million |
+11.03% |
| 2023-12-31 | €64.61 Million ≈ $75.54 Million |
+13.50% |
| 2022-12-31 | €56.93 Million ≈ $66.56 Million |
+25.46% |
| 2021-12-31 | €45.38 Million ≈ $53.05 Million |
+29.23% |
| 2020-12-31 | €35.11 Million ≈ $41.05 Million |
+18.88% |
| 2019-12-31 | €29.53 Million ≈ $34.53 Million |
+17.37% |
| 2018-12-31 | €25.16 Million ≈ $29.42 Million |
+18.11% |
| 2017-12-31 | €21.31 Million ≈ $24.91 Million |
+22.05% |
| 2016-12-31 | €17.46 Million ≈ $20.41 Million |
+16.62% |
| 2015-12-31 | €14.97 Million ≈ $17.50 Million |
+13.74% |
| 2014-12-31 | €13.16 Million ≈ $15.39 Million |
-1.39% |
| 2013-12-31 | €13.35 Million ≈ $15.60 Million |
-4.22% |
| 2012-12-31 | €13.93 Million ≈ $16.29 Million |
+2.71% |
| 2011-12-31 | €13.57 Million ≈ $15.86 Million |
-0.49% |
| 2010-12-31 | €13.63 Million ≈ $15.94 Million |
-27.88% |
| 2009-12-31 | €18.90 Million ≈ $22.10 Million |
-11.96% |
| 2008-12-31 | €21.47 Million ≈ $25.10 Million |
-10.22% |
| 2007-12-31 | €23.92 Million ≈ $27.96 Million |
+69.34% |
| 2006-12-31 | €14.12 Million ≈ $16.51 Million |
-54.63% |
| 2005-12-31 | €31.13 Million ≈ $36.40 Million |
-2.86% |
| 2004-12-31 | €32.05 Million ≈ $37.47 Million |
+8.04% |
| 2003-12-31 | €29.66 Million ≈ $34.68 Million |
+1.16% |
| 2002-12-31 | €29.32 Million ≈ $34.28 Million |
+12.04% |
| 2001-12-31 | €26.17 Million ≈ $30.60 Million |
+118.66% |
| 2000-12-31 | €11.97 Million ≈ $13.99 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Eurofins-Cerep SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 5547739200.0% over the analyzed period, indicating profitable operations and earnings retention.
Eurofins-Cerep SA Net Assets Breakdown (December 2025)
Eurofins-Cerep SA net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €55.48 Million | 72.66% |
| Common Stock | €75.66K | 0.10% |
| Other Comprehensive Income | €9.96 Million | 13.05% |
| Other Components | €10.84 Million | 14.19% |
| Total Equity | €76.35 Million | 100.00% |
Eurofins-Cerep SA Competitors by Market Cap
The table below lists competitors of Eurofins-Cerep SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Guerbet S. A.
PA:GBT
|
$91.82 Million |
|
Englewood Lab Inc
KQ:950140
|
$91.83 Million |
|
Dharmaj Crop Guard Limited
NSE:DHARMAJ
|
$91.89 Million |
|
Nabaltec AG
F:NTG
|
$91.96 Million |
|
Sree Rayalaseema Hi-Strength Hypo Limited
NSE:SRHHYPOLTD
|
$91.77 Million |
|
Turk Prysmian Kablo ve Sistemleri AS
IS:PRKAB
|
$91.76 Million |
|
Reworld Media
PA:ALREW
|
$91.73 Million |
|
CJ CheilJedang Corp
KO:097955
|
$91.68 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Eurofins-Cerep SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 71,740,048 to 76,353,844, a change of 4,613,796 (6.4%).
- Net income of 4,782,469 contributed positively to equity growth.
- Other comprehensive income decreased equity by 161,107.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €4.78 Million | +6.26% |
| Other Comprehensive Income | €-161.11K | -0.21% |
| Other Changes | €-7.57K | -0.01% |
| Total Change | €- | 6.43% |
Book Value vs Market Value Analysis
This analysis compares Eurofins-Cerep SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.22x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 3.05x to 1.22x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-12-31 | €6027.13 | €18400.00 | x |
| 2003-12-31 | €6136.33 | €18400.00 | x |
| 2004-12-31 | €6607.84 | €18400.00 | x |
| 2005-12-31 | €6290.36 | €18400.00 | x |
| 2006-12-31 | €2815.59 | €18400.00 | x |
| 2007-12-31 | €4766.21 | €18400.00 | x |
| 2008-12-31 | €4254.21 | €18400.00 | x |
| 2009-12-31 | €3747.82 | €18400.00 | x |
| 2010-12-31 | €2703.01 | €18400.00 | x |
| 2011-12-31 | €2689.73 | €18400.00 | x |
| 2012-12-31 | €2762.49 | €18400.00 | x |
| 2013-12-31 | €2627.17 | €18400.00 | x |
| 2014-12-31 | €2610.76 | €18400.00 | x |
| 2015-12-31 | €2967.74 | €18400.00 | x |
| 2016-12-31 | €3460.94 | €18400.00 | x |
| 2017-12-31 | €4502.75 | €18400.00 | x |
| 2018-12-31 | €4989.05 | €18400.00 | x |
| 2019-12-31 | €5855.40 | €18400.00 | x |
| 2020-12-31 | €6961.05 | €18400.00 | x |
| 2021-12-31 | €8995.88 | €18400.00 | x |
| 2022-12-31 | €11286.65 | €18400.00 | x |
| 2023-12-31 | €12810.20 | €18400.00 | x |
| 2024-12-31 | €14222.85 | €18400.00 | x |
| 2025-12-31 | €15137.56 | €18400.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Eurofins-Cerep SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 6.26%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 11.67%
- • Asset Turnover: 0.46x
- • Equity Multiplier: 1.16x
- Recent ROE (6.26%) is above the historical average (0.75%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2000 | 1.96% | 1.29% | 0.77x | 1.98x | €-961.90K |
| 2001 | 9.16% | 8.66% | 0.68x | 1.56x | €-220.10K |
| 2002 | 10.90% | 9.26% | 0.72x | 1.63x | €263.80K |
| 2003 | 1.55% | 1.35% | 0.67x | 1.73x | €-2.51 Million |
| 2004 | 8.62% | 5.38% | 0.80x | 1.99x | €-441.24K |
| 2005 | -21.50% | -12.65% | 0.63x | 2.69x | €-9.81 Million |
| 2006 | -119.92% | -32.06% | 0.69x | 5.41x | €-18.35 Million |
| 2007 | 38.12% | 29.12% | 0.50x | 2.61x | €6.76 Million |
| 2008 | -9.99% | -6.79% | 0.58x | 2.56x | €-4.29 Million |
| 2009 | -11.47% | -8.08% | 0.61x | 2.34x | €-4.06 Million |
| 2010 | -39.65% | -22.35% | 0.67x | 2.63x | €-6.77 Million |
| 2011 | -0.58% | -0.35% | 0.70x | 2.41x | €-1.44 Million |
| 2012 | 2.28% | 1.44% | 0.73x | 2.17x | €-1.08 Million |
| 2013 | -6.66% | -4.40% | 0.72x | 2.09x | €-2.22 Million |
| 2014 | -3.76% | -2.67% | 0.81x | 1.74x | €-1.81 Million |
| 2015 | 12.08% | 8.03% | 0.89x | 1.68x | €311.51K |
| 2016 | 14.24% | 10.61% | 0.90x | 1.49x | €740.32K |
| 2017 | 18.07% | 15.77% | 0.81x | 1.42x | €1.72 Million |
| 2018 | 15.33% | 15.16% | 0.72x | 1.40x | €1.34 Million |
| 2019 | 14.80% | 14.09% | 0.78x | 1.35x | €1.42 Million |
| 2020 | 15.88% | 17.07% | 0.71x | 1.31x | €2.07 Million |
| 2021 | 21.69% | 23.65% | 0.70x | 1.32x | €5.31 Million |
| 2022 | 20.24% | 24.20% | 0.67x | 1.25x | €5.83 Million |
| 2023 | 11.82% | 17.33% | 0.56x | 1.23x | €1.18 Million |
| 2024 | 9.97% | 17.68% | 0.48x | 1.17x | €-19.46K |
| 2025 | 6.26% | 11.67% | 0.46x | 1.16x | €-2.85 Million |
Industry Comparison
This section compares Eurofins-Cerep SA's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $858,575,725
- Average return on equity (ROE) among peers: 6.78%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Eurofins-Cerep SA (ALECR) | €76.41 Million | 1.96% | 0.16x | $91.80 Million |
| Predilife (ALPRE) | $-12.10K | 0.00% | 0.00x | $3.44 Million |
| Biomerieux SA (BIM) | $688.40 Million | 18.88% | 0.73x | $8.48 Billion |
| Eurofins Scientific SE (ERF) | $2.72 Billion | 8.23% | 1.65x | $10.22 Billion |
| Lumibird SA (LBIRD) | $23.73 Million | 0.00% | 1.92x | $489.86 Million |
About Eurofins-Cerep SA
Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally. The company also provides research services, including compound management, and high-throughout screening and profiling. The company was formerly known as Cerep SA and changed its name to Eurofins-Cerep SA in June 2014. Eurofins-Cerep SA was foun… Read more